mTOR is one of the downstream effectors of AKT [33] and the EGF receptor is an upstream activator of the PI3K/AKT pathway mutated in approximately 90% of HNSCC cases [34, 35]. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.